文献速递免疫规划卫生政策与健康促进

COVID-19疫苗对生育力的影响:系统综述与Meta分析

The impact of COVID-19 vaccines on fertility-A systematic review and meta-analysis.
PubMed 文献 · Vaccine · 2022-09-12

该系统综述与Meta分析检索截至2022年6月8日的多个数据库,纳入29项研究,评估COVID-19疫苗对育龄男女生育力的影响。Meta分析显示疫苗接种前后精子前向运动力、浓度及生化与临床妊娠率均无显著差异,亚组分析亦未发现显著差异。结论认为迄今发表的科学证据不支持COVID-19疫苗与男女生育力损害存在关联。

要点

  • 疫苗接种前后精子前向运动力及浓度无显著差异。
  • 接种与未接种组生化及临床妊娠率无显著差异。
  • mRNA疫苗、Gam-COVID-Vac及BNT162b2亚组分析均无显著差异。

核心结论

  • 基于迄今发表的研究,没有科学证据表明COVID-19疫苗与男性或女性生育力损害存在关联。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Scopus、Web of Science、Cochrane和Embase数据库直至2022年6月8日,纳入29项研究。
  • 纳入研究限定于人类,发表语言不限,无额外限制;采用纽卡斯尔-渥太华量表及前后质量评估量表分别评估队列研究和前后对照研究质量。

主要发现

  • 接种前后精子前向运动力为44%(95%CI 42%-62%)vs 43%(95%CI 31%-59%),P=0.07;精子浓度为50.6百万/ml(95%CI 35.1-72.8)vs 55.4百万/ml(95%CI 37.4-82.2),P=0.12。
  • 接种与未接种组生化妊娠率为0.51(95%CI 0.40-0.66)vs 0.60(95%CI 0.53-0.68),P=0.45;临床妊娠率为0.45(95%CI 0.37-0.54)vs 0.47(95%CI 0.40-0.55),P=0.31。
  • 基于疫苗类型的亚组Meta分析显示:mRNA疫苗接种者与未接种者生化妊娠率、Gam-COVID-Vac接种前后睾酮、FSH和LH水平、BNT162b2接种前后精液量均无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 纳入研究质量参差不齐:差34.5%、中等58.6%、好6.9%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite literature's evidence about COVID-19 vaccines' safety, concerns have arisen regarding adverse events, including the possible impact on fertility, accentuated by misinformation and anti-vaccine campaigns. The present study aims to answer the question: Is there any impact of COVID-19 vaccines on the fertility of men and women of reproductive age? METHODS: PubMed, Scopus, Web of Science, Cochrane and Embase databases were searched for eligible studies until June 8th, 2022. The search was restricted to articles regarding humans, published in any languages, without additional restrictions. Studies' quality was assessed by the Newcastle-Ottawa and the Before and After Quality Assessment scales for cohort and pre-post studies, respectively. Random-effect meta-analyses were performed for parameters considered in ≥ 2 studies, calculating means, p-values and 95 % Confidence Intervals (CIs). RESULTS: Out of 1406 studies screened, 29 were included in the systematic review. These studies, conducted in Israel (34.5 %), USA (24.1 %), Russia (20.7 %) China (10.3 %), Italy (3.5 %), North America (3.5%) and Turkey (3.5 %) were of poor (34.5 %), moderate (58.6 %) and good (6.9 %) quality. Meta-analyses were performed for pre- and post-vaccination sperm progressive motility (44 %, 95 % CI 42 %-62 % vs 43 %, 95 % CI 31 %-59 % p = 0.07) and concentration (50.6 mln/ml, 95 % CI 35.1-72.8 vs 55.4 mln/ml, 95 % CI 37.4-82.2p = 0.12). Biochemical (0.51, 95 % CI 0.40-0.66 vs 0.60, 95 % CI 0.53-0.68p = 0.45) and clinical (0.45, 95 % CI 0.37-0.54 vs 0.47, 95 % CI 0.40-0.55 p = 0.31) pregnancy rate did not differ among vaccinated and not vaccinated groups. Subgroup meta-analyses based on the type of vaccine showed no significant difference: between vaccinated with mRNA vaccines and non-vaccinated regarding biochemical pregnancy rates; pre- and post-vaccination with Gam-COVID-Vac regarding testosterone, FSH and LH levels; pre- and post-vaccination with BNT162b2 vaccines regarding sperm volumes. CONCLUSION: Based on the studies published so far, there is no scientific proof of any association between COVID-19 vaccines and fertility impairment in men or women.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zaçe D, La Gatta E, Petrella L, et al. The impact of COVID-19 vaccines on fertility-A systematic review and meta-analysis. Vaccine. 2022. PMID: 36137903. doi:10.1016/j.vaccine.2022.09.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。